Following positive trial data , retatrutide, a innovative peptide therapy for managing non-insulin dependent hyperglycemia , has secured regulatory approval from UK’s Medicines and Regulatory Agency ( https://shopretatrutidepeptide.com/category/retatrutide-peptide/